|
|
|
|
| LEADER |
01659nmm a2200409 u 4500 |
| 001 |
EB001902353 |
| 003 |
EBX01000000000000001065262 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
201006 ||| eng |
| 100 |
1 |
|
|a Crowe, James E.
|
| 245 |
0 |
0 |
|a SARS-CoV-2 human monoclonal antibody therapy
|h Elektronische Ressource
|c James Crowe
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2020, 2020
|
| 300 |
|
|
|a 1 streaming audio file (17 min.))
|
| 505 |
0 |
|
|a Contents: Overview on human monoclonal antibody research for COVID-19 -- Technologies used in this research -- The future of antibody therapy for COVID-19
|
| 653 |
|
|
|a COVID-19
|
| 653 |
|
|
|a Antiviral Agents
|
| 653 |
|
|
|a severe acute respiratory syndrome coronavirus 2
|
| 653 |
|
|
|a COVID-19 (Disease)
|
| 653 |
|
|
|a Immunization
|
| 653 |
|
|
|a Antibodies, Monoclonal / therapeutic use
|
| 653 |
|
|
|a Drug Development
|
| 653 |
|
|
|a Drug Discovery
|
| 653 |
|
|
|a Antibodies, Monoclonal / pharmacology
|
| 653 |
|
|
|a Coronavirus infections / Immunological aspects
|
| 653 |
|
|
|a Antiviral agents / Development
|
| 653 |
|
|
|a Monoclonal antibodies / Research
|
| 653 |
|
|
|a Coronavirus Infections / immunology
|
| 653 |
|
|
|a Monoclonal antibodies / Therapeutic use
|
| 653 |
|
|
|a Coronavirus Infections / drug therapy
|
| 653 |
|
|
|a Coronavirus infections / Chemotherapy
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Research and clinical interviews
|
| 500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4293
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|